[ad_1] Mohit Bansal, a Wells Fargo analyst, stated that although the pace of deals in biotech is expected to increase, investors need to consider smaller
[ad_1] Traders have been laser-focused on profit-producing firms, which has left firms of their pre-revenue stage on the sidelines. Because of this, a rising variety
[ad_1] Take a look at the businesses making headlines earlier than the bell: Turning Point Therapeutics (TPTX) – The biopharmaceutical firm’s shares greater than doubled
[ad_1] Markets have logged wild swings in latest weeks and the brand new month kicked off Wednesday in related vogue. However even in an unpredictable
[ad_1] This group of stocks, despite market losses mounting up was still breaking out at all-time highs. It looks like they are poised for more
[ad_1] The Alps Sector Dividend Dogs ETF is a great safe-haven option for investors who are facing a turbulent 2022. [ad_2]
[ad_1] Energy, basic materials and healthcare drove outperformance this year for J.P. Morgan's large-cap value fund. [ad_2]
[ad_1] Vlad Tenev, CEO and co-founder Robinhood Markets, Inc., is displayed on a screen during his company’s IPO at the Nasdaq Market site in Times
[ad_1] It is becoming increasingly clear that the alarm about imminent recession is getting stronger. Investors need to pay attention. [ad_2]
[ad_1] Potentially, investors are missing out on an opportunity: stocks in health-care companies. [ad_2]
View More